Your browser doesn't support javascript.
loading
Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer.
Chen, Zhong; Lan, Xun; Thomas-Ahner, Jennifer M; Wu, Dayong; Liu, Xiangtao; Ye, Zhenqing; Wang, Liguo; Sunkel, Benjamin; Grenade, Cassandra; Chen, Junsheng; Zynger, Debra L; Yan, Pearlly S; Huang, Jiaoti; Nephew, Kenneth P; Huang, Tim H-M; Lin, Shili; Clinton, Steven K; Li, Wei; Jin, Victor X; Wang, Qianben.
Afiliação
  • Chen Z; Department of Molecular Virology, Immunology and Medical Genetics and the Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Lan X; Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Thomas-Ahner JM; Division of Medical Oncology, Department of Internal Medicine and the Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Wu D; Department of Molecular Virology, Immunology and Medical Genetics and the Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Liu X; Department of Molecular Virology, Immunology and Medical Genetics and the Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Ye Z; Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH, USA Department of Molecular Medicine, Cancer Therapy and Research Center, University of Texas Health Science Center, San Antonio, TX, USA.
  • Wang L; Division of Biostatistics, Dan L. Duncan Cancer Center Baylor College of Medicine, Houston, TX, USA Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
  • Sunkel B; Department of Molecular Virology, Immunology and Medical Genetics and the Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Grenade C; Department of Molecular Virology, Immunology and Medical Genetics and the Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Chen J; Division of Biostatistics, Dan L. Duncan Cancer Center Baylor College of Medicine, Houston, TX, USA Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
  • Zynger DL; Department of Pathology, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Yan PS; Department of Molecular Virology, Immunology and Medical Genetics and the Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Huang J; Departments of Pathology and Urology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA Broad Center for Regenerative Medicine and Stem Cell Research, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Nephew KP; Medical Sciences Program, Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Bloomington, IN, USA.
  • Huang TH; Department of Molecular Medicine, Cancer Therapy and Research Center, University of Texas Health Science Center, San Antonio, TX, USA.
  • Lin S; Department of Statistics, The Ohio State University, Columbus, OH, USA.
  • Clinton SK; Division of Medical Oncology, Department of Internal Medicine and the Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Li W; Division of Biostatistics, Dan L. Duncan Cancer Center Baylor College of Medicine, Houston, TX, USA Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
  • Jin VX; Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH, USA Department of Molecular Medicine, Cancer Therapy and Research Center, University of Texas Health Science Center, San Antonio, TX, USA.
  • Wang Q; Department of Molecular Virology, Immunology and Medical Genetics and the Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, USA qianben.wang@osumc.edu.
EMBO J ; 34(4): 502-16, 2015 Feb 12.
Article em En | MEDLINE | ID: mdl-25535248
ABSTRACT
Human transcription factors recognize specific DNA sequence motifs to regulate transcription. It is unknown whether a single transcription factor is able to bind to distinctly different motifs on chromatin, and if so, what determines the usage of specific motifs. By using a motif-resolution chromatin immunoprecipitation-exonuclease (ChIP-exo) approach, we find that agonist-liganded human androgen receptor (AR) and antagonist-liganded AR bind to two distinctly different motifs, leading to distinct transcriptional outcomes in prostate cancer cells. Further analysis on clinical prostate tissues reveals that the binding of AR to these two distinct motifs is involved in prostate carcinogenesis. Together, these results suggest that unique ligands may switch DNA motifs recognized by ligand-dependent transcription factors in vivo. Our findings also provide a broad mechanistic foundation for understanding ligand-specific induction of gene expression profiles.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / DNA / Receptores Androgênicos / Antagonistas de Receptores de Andrógenos / Androgênios Limite: Humans / Male Idioma: En Revista: EMBO J Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / DNA / Receptores Androgênicos / Antagonistas de Receptores de Andrógenos / Androgênios Limite: Humans / Male Idioma: En Revista: EMBO J Ano de publicação: 2015 Tipo de documento: Article